Chair: J Compston

IOF Members: R Adachi, D Agnusdei, J Bilezikian, S Boonen, F Borgström, C Cooper, J Kanis, S Lekawasam, R Lorenc, E McCloskey, O Messina, N Napoli, P Sambrook, S Silverman, M Sosa, J Stepan

ECTS Members: L Hofbauer, B Langdahl, B Obermayer Pietsch, S Ralston

IOF and ECCTS Members: A Diez Perez, R Eastell 

Patient society representatives: G Suppan - Austrian Society (Action for Healthy Bones), O Lesnyak (Russian Association on Osteoporosis)

Few guidelines exist that specifically address GIOP and those that do exist need to be updated particularly with respect to the use of FRAX in risk assessment and some of the more newly approved interventions.

1. Lekamwasam, S., et al., A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int, 2012. 23(9): p. 2257-76.
2. Lekamwasam, S., et al., An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Arch Osteoporos, 2012. 7: p. 25-30.